Vendor Intelligence Report: Shanghai Baoju

Executive summary

Across 85 Finnrick lab tests, Shanghai Baoju records 67 pass / 18 fail, an overall pass rate of 79%. The headline number is useful, but it hides an uneven catalog: GHK-Cu is the cleanest Baoju lane, Retatrutide is more defensible than Tirzepatide in the current block, and TB-500 is the product that should be treated as avoid-or-test.

The lab story is not just purity. The report flags methodology sensitivity: the public purity-focused view is more forgiving than stricter fill-accuracy views, which matters for small repeated doses. Retatrutide also shows a traceability problem in row-level captures, with unlabeled or no-batch descriptors that make COA matching and recalls impractical even when chemistry passes.

Behind the product data, the company trail is recent and fragmented. GlobalSources and LookChem tell different establishment stories, while domain and Wayback records compress the observed storefront into the recent public trail; the Chinese registry match remains unresolved. A GlobalSources warning about WhatsApp and WeChat contact is especially relevant because Baoju’s observed sales path leans on messenger channels.

The network work is equally important for buyers trying to avoid impersonation or brand confusion. A UK-format WhatsApp setup, a separate email domain, and Telegram handles reduce canonical-channel clarity. The lucypepti persona appears on Baoju material and separately points to Henan Zhitai / ZZTaiTech assets; the evidence supports operational overlap, not a proven ownership conclusion.

Inside the full report:

• Per-product pass/fail rates, methodology-divergence charts, and Appendix A lab data for all 8 products
• Domain-registration and Wayback timeline contrasting long-history claims with the observed storefront record
• Corporate-identity analysis covering GlobalSources, LookChem, Allbiz director/address leads, and the unresolved SAMR gap
• Contact-channel map of baojuchemical.com, baojuxcl.com, UK WhatsApp numbers, and Telegram personas
• Persona/network analysis linking lucypepti to Henan Zhitai, ZZTaiTech, and related domains
• Promotion scan covering public X/web coupon silence and the undisclosed Peppys invite lead

Risk assessment

• TB-500 quality risk — high: TB-500 is fail-heavy in the current block: 4 tests, 1 pass / 3 fail, 32.4%; avoid unless the exact lot is independently tested.
• BPC-157 quality risk — medium: BPC-157 has 6 tests, 4 pass / 2 fail, 56.31%; two failures make blind buying from Baoju a poor choice.
• Tirzepatide quality risk — medium: Tirzepatide has 24 tests, 18 pass / 6 fail, 76.67%; lot-level verification is needed for this dose-sensitive product.
• Ipamorelin and Tesamorelin quality risk — medium: Ipamorelin has 5 tests, 3 pass / 2 fail, 66.45%; Tesamorelin has 4 tests, 3 pass / 1 fail, 51.83%; both are thin and weak enough to require exact-lot testing.
• Corporate-history and supplier-verification risk — high: Long-history and factory-scale claims conflict with 2024 domain / LookChem records, a GlobalSources warning, and unresolved SAMR verification.
• Batch-traceability and COA-verification risk — high: The vendor site lacks a public third-party COA-verification mechanism, and captured Retatrutide rows show unlabeled / no-batch vials that cannot be matched to lot reports.
• Contact-channel and brand-confusion risk — medium: UK WhatsApp numbers, a separate email domain, Telegram personas, Henan Zhitai / Baoju Chemical overlap, and no authorized-channel list create authenticity risk.
• Undisclosed Peppys referral-promotion risk — medium: One Reddit account repeatedly shared a Peppys invite link without disclosure; direct Baoju compensation is not proven, but the referral funnel touches the vendor ecosystem.